×

Teva Scoops Up Barr

1:06 PM ET Fri, 18 July 2008

Generic drug giant Teva Pharmaceuticals bought rival Barr for $7 billion, and some analysts say this could spark a big wave of consolidation. CNBC's Mike Huckman has the details.